首页 > 最新文献

Brain Hemorrhages最新文献

英文 中文
Detection and successful endovascular treatment for a de novo intracranial pseudoaneurysm in early phase after traumatic brain injury 脑外伤后早期颅内新发假性动脉瘤的检测和成功血管内治疗
Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.hest.2023.04.002
Sosho Kajiwara , Shuichi Tanoue , Masaru Hirohata , Yasuharu Takeuchi , Yu Hasegawa , Kimihiko Orito , Toshi Abe , Motohiro Morioka

Traumatic intracranial pseudoaneurysm (TIP) after head trauma is rare, but it frequently ruptures in early phase. Although early detection and prompt treatment is important, the details are still unknown. Here, we report a case who was diagnosed with TIP in early phase after trauma and underwent endovascular treatment with parent artery occlusion (PAO), resulted in a good outcome.

A 17-year-old boy hospitalized for severe head trauma. Computed tomography (CT) revealed an acute epidural hematoma (AEDH) in the right middle fossa along with the fracture from the right lateral optic canal to the right superior orbital fissure, and CT angiography showed no obvious aneurysm at that time. CT angiography on 5 days showed an irregular shaped aneurysm at a C2-C3 posterior wall in the right internal carotid artery (ICA). As balloon occlusion test revealed complete ischemic tolerance, endovascular PAO was performed without any bypass. Postoperative imaging showed no hypoperfusion area.

Prompt diagnosis for TIP is important and the patients with skull fracture around ICA area are considered to provide cerebral angiography in early phase. In addition, TIP in early phase has a risk of rupture, suitable treatment strategy using BOT is important for the favorable outcome in those patients.

头部外伤后的外伤性颅内假性动脉瘤(TIP)非常罕见,但经常在早期破裂。虽然早期发现和及时治疗很重要,但具体情况仍不清楚。在此,我们报告了一例在外伤后早期被诊断为 TIP 的病例,该病例接受了母动脉闭塞(PAO)的血管内治疗,结果良好。计算机断层扫描(CT)显示右侧中窝有急性硬膜外血肿(AEDH),右侧外侧视神经管至右眶上裂骨折,CT 血管造影显示当时无明显动脉瘤。5 天后的 CT 血管造影显示,右侧颈内动脉(ICA)C2-C3 后壁有一个形状不规则的动脉瘤。由于球囊闭塞试验显示完全缺血耐受,因此在没有任何旁路的情况下进行了血管内PAO手术。术后造影显示没有低灌注区。TIP的及时诊断非常重要,ICA区域周围有颅骨骨折的患者应考虑在早期进行脑血管造影。此外,早期的 TIP 有破裂的风险,使用 BOT 的适当治疗策略对这些患者的良好预后非常重要。
{"title":"Detection and successful endovascular treatment for a de novo intracranial pseudoaneurysm in early phase after traumatic brain injury","authors":"Sosho Kajiwara ,&nbsp;Shuichi Tanoue ,&nbsp;Masaru Hirohata ,&nbsp;Yasuharu Takeuchi ,&nbsp;Yu Hasegawa ,&nbsp;Kimihiko Orito ,&nbsp;Toshi Abe ,&nbsp;Motohiro Morioka","doi":"10.1016/j.hest.2023.04.002","DOIUrl":"10.1016/j.hest.2023.04.002","url":null,"abstract":"<div><p>Traumatic intracranial pseudoaneurysm (TIP) after head trauma is rare, but it frequently ruptures in early phase. Although early detection and prompt treatment is important, the details are still unknown. Here, we report a case who was diagnosed with TIP in early phase after trauma and underwent endovascular treatment with parent artery occlusion (PAO), resulted in a good outcome.</p><p>A 17-year-old boy hospitalized for severe head trauma. Computed tomography (CT) revealed an acute epidural hematoma (AEDH) in the right middle fossa along with the fracture from the right lateral optic canal to the right superior orbital fissure, and CT angiography showed no obvious aneurysm at that time. CT angiography on 5 days showed an irregular shaped aneurysm at a C2-C3 posterior wall in the right internal carotid artery (ICA). As balloon occlusion test revealed complete ischemic tolerance, endovascular PAO was performed without any bypass. Postoperative imaging showed no hypoperfusion area.</p><p>Prompt diagnosis for TIP is important and the patients with skull fracture around ICA area are considered to provide cerebral angiography in early phase. In addition, TIP in early phase has a risk of rupture, suitable treatment strategy using BOT is important for the favorable outcome in those patients.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 4","pages":"Pages 210-214"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589238X2300013X/pdfft?md5=c2db712b1d6b41f1f4871389db362776&pid=1-s2.0-S2589238X2300013X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73209630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Call for papers: Special issue on immune and peri-vascular cells in brain hemorrhage 征集论文:脑出血中的免疫细胞和血管周围细胞特刊
Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.hest.2023.11.003
Iris Tang
{"title":"Call for papers: Special issue on immune and peri-vascular cells in brain hemorrhage","authors":"Iris Tang","doi":"10.1016/j.hest.2023.11.003","DOIUrl":"10.1016/j.hest.2023.11.003","url":null,"abstract":"","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 4","pages":"Page 221"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589238X23000475/pdfft?md5=a206dbb872b2630d72232b8110cb330e&pid=1-s2.0-S2589238X23000475-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135514899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intranasal administration of collagenase develops cerebral microbleeds and vascular dementia in mice: In vivo pilot study 鼻内注射胶原酶会导致小鼠出现脑微出血和血管性痴呆:体内试验研究
Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.hest.2023.05.001
Kenyu Hayashi , Prativa Sherchan , John H. Zhang , Yu Hasegawa

Objective

To establish a new animal model of lobar cerebral microbleeds (CMBs), we examined whether intranasal administration of collagenase induced CMBs in young mice which did not have hypertensive pathologic features.

Methods

We used thirty-two male CD1 mice (8–10 weeks old), which were received either phosphate-buffered saline (PBS) or collagenase by intranasal administration twice a day for 5 days. A dose response study was conducted, and motor function and number of CMBs was evaluated at one day after completing the intranasal administration. Temporal profile of cognitive impairment and number of CMBs through 7 days was evaluated after completing intranasal administration of 3.6U collagenase.

Results

The number of CMBs showed an increasing trend in a dose-dependent manner and higher number of CMBs were observed with 3.6U collagenase. Cognitive impairment and CMBs was observed in 3.6U collagenase groups up to 7 days after administration. In addition, successful brain delivery via intranasal route was comfirmed by administering fluorescein isothiocyanate-labeled bovine serum albumin.

Conclusions

Intranasal collagenase administration is a feasible and minimally invasive method to produce CMBs and cognitive impairment in mice. This model has potential for producing CMBs in animals with cerebral amyloid angiopathy such as transgenic mice models of Alzheimer’s disease.

方法 我们使用 32 只雄性 CD1 小鼠(8-10 周大),给它们注射磷酸盐缓冲盐水(PBS)或胶原酶,每天两次,连续 5 天。进行剂量反应研究,并在完成鼻内给药一天后评估运动功能和 CMB 数量。在完成 3.6U 胶原酶鼻内给药 7 天后,对认知障碍和 CMBs 数量的时间曲线进行了评估。3.6U 胶原酶组在用药 7 天后出现认知障碍和 CMB。结论经鼻胶原酶给药是一种可行的微创方法,可产生 CMBs 和小鼠认知障碍。该模型有望在脑淀粉样血管病变动物(如阿尔茨海默病转基因小鼠模型)中产生 CMB。
{"title":"Intranasal administration of collagenase develops cerebral microbleeds and vascular dementia in mice: In vivo pilot study","authors":"Kenyu Hayashi ,&nbsp;Prativa Sherchan ,&nbsp;John H. Zhang ,&nbsp;Yu Hasegawa","doi":"10.1016/j.hest.2023.05.001","DOIUrl":"10.1016/j.hest.2023.05.001","url":null,"abstract":"<div><h3>Objective</h3><p>To establish a new animal model of lobar cerebral microbleeds (CMBs), we examined whether intranasal administration of collagenase induced CMBs in young mice which did not have hypertensive pathologic features.</p></div><div><h3>Methods</h3><p>We used thirty-two male CD1 mice (8–10 weeks old), which were received either phosphate-buffered saline (PBS) or collagenase by intranasal administration twice a day for 5 days. A dose response study was conducted, and motor function and number of CMBs was evaluated at one day after completing the intranasal administration. Temporal profile of cognitive impairment and number of CMBs through 7 days was evaluated after completing intranasal administration of 3.6U collagenase.</p></div><div><h3>Results</h3><p>The number of CMBs showed an increasing trend in a dose-dependent manner and higher number of CMBs were observed with 3.6U collagenase. Cognitive impairment and CMBs was observed in 3.6U collagenase groups up to 7 days after administration. In addition, successful brain delivery via intranasal route was comfirmed by administering fluorescein isothiocyanate-labeled bovine serum albumin.</p></div><div><h3>Conclusions</h3><p>Intranasal collagenase administration is a feasible and minimally invasive method to produce CMBs and cognitive impairment in mice. This model has potential for producing CMBs in animals with cerebral amyloid angiopathy such as transgenic mice models of Alzheimer’s disease.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 4","pages":"Pages 183-188"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589238X23000219/pdfft?md5=4a230da9cc5623989a30f27da0250028&pid=1-s2.0-S2589238X23000219-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87335657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Middle meningeal artery embolization may be an effective treatment for patients with chronic subdural hematoma resistant to atorvastatin 脑膜中动脉栓塞术可有效治疗对阿托伐他汀耐药的慢性硬膜下血肿患者
Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.hest.2023.08.001
Yin Niu , Zhouyang Jiang , Yujie Chen, Gang Zhu, Hua Feng, Zhi Chen

Objective

To investigate the efficacy and safety of MMA embolization in patients with CSDH who failed atorvastatin treatment.

Methods

Seventeen CSDH patients who failed atorvastatin treatment from Jan 1, 2021 to Dec 31, 2021 were included in the study. All patients were treated with MMA embolization using polyvinyl alcohol (PVA) particles.

Results

Twenty-six MMAs (unilateral embolization in 8 patients and bilateral embolization in 9 patients) were successfully embolized in all patients. Hematoma re-accumulated in only one patient (5.9%) after MMA embolization and was surgically evacuated. Procedural adverse events, mortality, or complications were not observed. At the last follow-up of an average of 51.5 days post MMA embolization, maximum hematoma thickness improved in 95.2% of CSDHs with a mean reduction of 52.1%, while mRS score improved in 94.1% of patients. In addition, 5 (29.4%) patients with unilateral hematoma underwent bilateral MMA embolization and hematoma absorbed completely in all 5 cases.

Conclusions

MMA embolization may be a minimally invasive alternative to surgical evacuation for CSDH patients resistant to atorvastatin. In unilateral CSDH, bilateral superselective angiography and bilateral MMA embolization could be a useful and effective treatment strategy.

目的 探讨阿托伐他汀治疗失败的 CSDH 患者接受 MMA 栓塞治疗的疗效和安全性。方法 纳入 2021 年 1 月 1 日至 2021 年 12 月 31 日阿托伐他汀治疗失败的 17 例 CSDH 患者。结果所有患者均成功栓塞了 26 个 MMA(8 例患者单侧栓塞,9 例患者双侧栓塞)。仅有一名患者(5.9%)在 MMA 栓塞后血肿再次积聚,并通过手术排出。未观察到手术不良事件、死亡率或并发症。在 MMA 栓塞术后平均 51.5 天的最后一次随访中,95.2% 的 CSDH 最大血肿厚度有所改善,平均减少 52.1%,94.1% 的患者 mRS 评分有所改善。此外,5 例(29.4%)单侧血肿患者接受了双侧 MMA 栓塞治疗,5 例患者的血肿均完全吸收。对于单侧 CSDH,双侧超选择性血管造影和双侧 MMA 栓塞术可能是一种有效的治疗策略。
{"title":"Middle meningeal artery embolization may be an effective treatment for patients with chronic subdural hematoma resistant to atorvastatin","authors":"Yin Niu ,&nbsp;Zhouyang Jiang ,&nbsp;Yujie Chen,&nbsp;Gang Zhu,&nbsp;Hua Feng,&nbsp;Zhi Chen","doi":"10.1016/j.hest.2023.08.001","DOIUrl":"10.1016/j.hest.2023.08.001","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the efficacy and safety of MMA embolization in patients with CSDH who failed atorvastatin treatment.</p></div><div><h3>Methods</h3><p>Seventeen CSDH patients who failed atorvastatin treatment from Jan 1, 2021 to Dec 31, 2021 were included in the study. All patients were treated with MMA embolization using polyvinyl alcohol (PVA) particles.</p></div><div><h3>Results</h3><p>Twenty-six MMAs (unilateral embolization in 8 patients and bilateral embolization in 9 patients) were successfully embolized in all patients. Hematoma re-accumulated in only one patient (5.9%) after MMA embolization and was surgically evacuated. Procedural adverse events, mortality, or complications were not observed. At the last follow-up of an average of 51.5 days post MMA embolization, maximum hematoma thickness improved in 95.2% of CSDHs with a mean reduction of 52.1%, while mRS score improved in 94.1% of patients. In addition, 5 (29.4%) patients with unilateral hematoma underwent bilateral MMA embolization and hematoma absorbed completely in all 5 cases.</p></div><div><h3>Conclusions</h3><p>MMA embolization may be a minimally invasive alternative to surgical evacuation for CSDH patients resistant to atorvastatin. In unilateral CSDH, bilateral superselective angiography and bilateral MMA embolization could be a useful and effective treatment strategy.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 4","pages":"Pages 195-200"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589238X23000256/pdfft?md5=86fe51f29ccdedf16c784becaaddf3c6&pid=1-s2.0-S2589238X23000256-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75430274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Call for papers: Special issue on brain aneurysms and subarachnoid hemorrhage 征集论文:脑动脉瘤和蛛网膜下腔出血特刊
Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.hest.2023.11.002
Iris Tang
{"title":"Call for papers: Special issue on brain aneurysms and subarachnoid hemorrhage","authors":"Iris Tang","doi":"10.1016/j.hest.2023.11.002","DOIUrl":"10.1016/j.hest.2023.11.002","url":null,"abstract":"","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 4","pages":"Page 222"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589238X23000463/pdfft?md5=3e72ca3405efb16ea0b98b74ca07fe45&pid=1-s2.0-S2589238X23000463-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135456548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Special issue trailer: Clazosentan, first approval in Japan: Has perioperative management of subarachnoid hemorrhage changed? 特刊预告片:日本首次批准使用氯唑生坦:蛛网膜下腔出血的围手术期管理是否发生了变化?
Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.hest.2023.11.004
Iris Tang
{"title":"Special issue trailer: Clazosentan, first approval in Japan: Has perioperative management of subarachnoid hemorrhage changed?","authors":"Iris Tang","doi":"10.1016/j.hest.2023.11.004","DOIUrl":"10.1016/j.hest.2023.11.004","url":null,"abstract":"","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 4","pages":"Pages 219-220"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589238X23000487/pdfft?md5=d743a4519c27e0e9904c04b113a7769b&pid=1-s2.0-S2589238X23000487-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135564803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical study of CT-assisted positioning and bone marking-oriented transcerebellar aspiration of brainstem hemorrhage ct辅助定位及骨标记导向经小脑穿刺治疗脑干出血的临床研究
Q4 CLINICAL NEUROLOGY Pub Date : 2023-09-01 DOI: 10.1016/j.hest.2023.03.001
Danyang Chen , Jinhua Yang , Robert P. Ostrowski , Yunjie Li , Yuxiong Wang , Zeyu Li , Yong Yang , Shiquan Li , Jieming Li , Simin Li , Yonghui Xiong , Shuisheng Rong , Chao Pan , Zhouping Tang

Sixty-three patients admitted to 5 hospitals in 2014–2020 for the treatment of severe hypertensive brainstem hemorrhage by CT-guided and bone marker-oriented transcerebellar aspiration were enrolled in this study. The puncture accuracy, duration of hematoma removal, tracheal decannulation, postoperative complications, postoperative consciousness recovery time, Glasgow Outcome Scale (GOS) score, and prognosis outcome at follow-up were retrospectively analyzed. Additionally, the relationship between admission Glasgow Coma Scale (GCS) score and GOS score, and between hematoma volume and prognosis of patients was analyzed at follow-up. Results showed that CT localization–based and bone marker oriented transcerebellar hematoma aspiration in the treatment of severe hypertensive brainstem hemorrhage ensures high puncture accuracy, relatively low surgery risk, and good prognosis. The prognosis relates to the state of consciousness and hematoma volume.

本研究纳入了2014-2012年5家医院收治的63名患者,他们通过CT引导和骨标记导向的小脑穿刺治疗严重高血压脑干出血。对穿刺准确性、血肿清除时间、气管插管、术后并发症、术后意识恢复时间、格拉斯哥预后量表(GOS)评分和随访预后进行回顾性分析。此外,在随访中分析了入院格拉斯哥昏迷评分(GCS)与GOS评分之间的关系,以及血肿体积与患者预后之间的关系。结果表明,基于CT定位和骨标志物导向的小脑血肿抽吸治疗重型高血压脑干出血,穿刺准确率高,手术风险相对较低,预后良好。预后与意识状态和血肿体积有关。
{"title":"Clinical study of CT-assisted positioning and bone marking-oriented transcerebellar aspiration of brainstem hemorrhage","authors":"Danyang Chen ,&nbsp;Jinhua Yang ,&nbsp;Robert P. Ostrowski ,&nbsp;Yunjie Li ,&nbsp;Yuxiong Wang ,&nbsp;Zeyu Li ,&nbsp;Yong Yang ,&nbsp;Shiquan Li ,&nbsp;Jieming Li ,&nbsp;Simin Li ,&nbsp;Yonghui Xiong ,&nbsp;Shuisheng Rong ,&nbsp;Chao Pan ,&nbsp;Zhouping Tang","doi":"10.1016/j.hest.2023.03.001","DOIUrl":"https://doi.org/10.1016/j.hest.2023.03.001","url":null,"abstract":"<div><p>Sixty-three patients admitted to 5 hospitals in 2014–2020 for the treatment of severe hypertensive brainstem hemorrhage by CT-guided and bone marker-oriented transcerebellar aspiration were enrolled in this study. The puncture accuracy, duration of hematoma removal, tracheal decannulation, postoperative complications, postoperative consciousness recovery time, Glasgow Outcome Scale (GOS) score, and prognosis outcome at follow-up were retrospectively analyzed. Additionally, the relationship between admission Glasgow Coma Scale (GCS) score and GOS score, and between hematoma volume and prognosis of patients was analyzed at follow-up. Results showed that CT localization–based and bone marker oriented transcerebellar hematoma aspiration in the treatment of severe hypertensive brainstem hemorrhage ensures high puncture accuracy, relatively low surgery risk, and good prognosis. The prognosis relates to the state of consciousness and hematoma volume.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 3","pages":"Pages 116-121"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49746185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Off-label use of Woven EndoBridge device in vertebro-basilar junction aneurysm and a review of the literature 标签外应用Woven EndoBridge装置治疗椎基底交界处动脉瘤及文献回顾
Q4 CLINICAL NEUROLOGY Pub Date : 2023-09-01 DOI: 10.1016/j.hest.2022.10.007
Shail Thanki , Hannah Goldman-Daleo , Kunal Vakharia

An intrasaccular flow diverter, the Woven EndoBridge device has emerged as an alternate intervention for complex aneurysms of the ACA, MCA, ICA, and basilar artery. However, few studies report the use of the WEB device in off-label locations. This case report aims to contribute to this limited collection of data. We present a case of a 53-year-old male presenting with occipital headaches, found to have vertebrobasilar junction aneurysm. The WEB device was successfully used to embolize a large aneurysm of the vertebrobasilar junction, a current off-label location. This represents a new use of the WEB device, as well as an approach that addresses the limitations of other techniques used for vertebrobasilar junction aneurysms.

Woven EndoBridge装置是一种accular内分流器,已成为ACA、MCA、ICA和基底动脉复杂动脉瘤的替代干预措施。然而,很少有研究报告在标签外位置使用WEB设备。本案例报告旨在为这一有限的数据收集做出贡献。我们报告一例53岁男性枕部头痛,发现有椎基底动脉瘤。WEB装置成功地用于栓塞椎基底动脉交界处的大动脉瘤,这是目前的一个标签外位置。这代表了WEB设备的一种新用途,以及一种解决椎基底动脉瘤其他技术局限性的方法。
{"title":"Off-label use of Woven EndoBridge device in vertebro-basilar junction aneurysm and a review of the literature","authors":"Shail Thanki ,&nbsp;Hannah Goldman-Daleo ,&nbsp;Kunal Vakharia","doi":"10.1016/j.hest.2022.10.007","DOIUrl":"https://doi.org/10.1016/j.hest.2022.10.007","url":null,"abstract":"<div><p>An intrasaccular flow diverter, the Woven EndoBridge device has emerged as an alternate intervention for complex aneurysms of the ACA, MCA, ICA, and basilar artery. However, few studies report the use of the WEB device in off-label locations. This case report aims to contribute to this limited collection of data. We present a case of a 53-year-old male presenting with occipital headaches, found to have vertebrobasilar junction aneurysm. The WEB device was successfully used to embolize a large aneurysm of the vertebrobasilar junction, a current off-label location. This represents a new use of the WEB device, as well as an approach that addresses the limitations of other techniques used for vertebrobasilar junction aneurysms.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 3","pages":"Pages 129-131"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49746187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of subarachnoid hemorrhage due to perimedullary arteriovenous fistula with multiple feeders at the craniocervical junction cured by treating the common draining vein and a review of the literature 颅颈交界处多管动静脉瘘所致蛛网膜下腔出血1例,经共同引流静脉治疗并文献复习
Q4 CLINICAL NEUROLOGY Pub Date : 2023-09-01 DOI: 10.1016/j.hest.2023.01.003
Sho Sato, Satoshi Fujita, Yu Hiramoto, Morito Hayashi, Naoki Kushida, Nozomi Hirai, Haruo Nakayama, Norihiko Saito, Keisuke Ito, Takatoshi Sakurai, Satoshi Iwabuchi

Objective

Craniocervical junction arteriovenous fistula (CCJ-AVF) is a rare disease, and preoperative imaging evaluation is important in developing treatment strategies due to the complexity of the vascular architecture, such as the feeding vessels, shunt points, and draining veins. In the present study, we report a case of hemorrhagic perimedullary CCJ-AVF with multiple feeding vessels in which the common single draining vein was dissected by craniotomy and completely treated.

Case presentation

A 71-year-old woman presented with subarachnoid hemorrhage (Hunt & Kosnik, grade II). Cerebrovascular CTA showed no intracranial cerebral aneurysm and findings suggestive of shunt disease at the CCJ. Based on cerebral angiography, the patient was diagnosed with perimedullary CCJ AVF, with the right radicular and the left anterior spinal arteries as feeders which drain into a common dilated coronary vein through a shunt located on the ventral side of the spinal cord and then drain into the ascending and descending anterior spinal veins. Ventricular drainage was performed for acute hydrocephalus, and arteriovenous fistula was dissected electively by craniotomy on day 17 after onset. A clip was applied to the single draining vein, which had been evaluated using preoperative imaging diagnosis. Intraoperative digital subtraction angiography (DSA) confirmed the disappearance of shunt blood flow, and the surgery was completed. The follow-up DSA did not show shunt blood flow, and the patient was transferred to a rehabilitation hospital with a modified Rankin scale score of 2.

Conclusion

CCJ-AVF cases often have a complex vascular architecture, and it is important to use various modalities to understand the vascular anatomy in detail and develop an appropriate treatment strategy.

目的脑颈交界动静脉瘘(CCJ-AVF)是一种罕见的疾病,由于其血管结构(如供血血管、分流点和引流静脉)的复杂性,术前影像学评估对制定治疗策略具有重要意义。在本研究中,我们报告了一例出血性髓周CCJ-AVF伴多条供血血管,其中通过开颅术解剖并完全治疗了常见的单一引流静脉。病例介绍:一位71岁的女性出现蛛网膜下腔出血(Hunt&;Kosnik,II级)。脑血管CTA未显示颅内脑动脉瘤,提示CCJ存在分流疾病。根据脑血管造影,患者被诊断为髓周CCJ AVF,以右神经根和左脊髓前动脉为馈线,通过位于脊髓腹侧的分流器流入共同扩张的冠状静脉,然后流入上行和下行的脊髓前静脉。急性脑积水行心室引流,发病后第17天选择性开颅解剖动静脉瘘。将夹子应用于单一引流静脉,该静脉已通过术前影像学诊断进行了评估。术中数字减影血管造影术(DSA)证实分流血流消失,手术完成。随访DSA未显示分流血流,患者被转移到康复医院,改良Rankin量表评分为2。结论CCJ-AVF病例通常具有复杂的血管结构,使用各种方法详细了解血管解剖结构并制定适当的治疗策略很重要。
{"title":"A case of subarachnoid hemorrhage due to perimedullary arteriovenous fistula with multiple feeders at the craniocervical junction cured by treating the common draining vein and a review of the literature","authors":"Sho Sato,&nbsp;Satoshi Fujita,&nbsp;Yu Hiramoto,&nbsp;Morito Hayashi,&nbsp;Naoki Kushida,&nbsp;Nozomi Hirai,&nbsp;Haruo Nakayama,&nbsp;Norihiko Saito,&nbsp;Keisuke Ito,&nbsp;Takatoshi Sakurai,&nbsp;Satoshi Iwabuchi","doi":"10.1016/j.hest.2023.01.003","DOIUrl":"https://doi.org/10.1016/j.hest.2023.01.003","url":null,"abstract":"<div><h3>Objective</h3><p>Craniocervical junction arteriovenous fistula (CCJ-AVF) is a rare disease, and preoperative imaging evaluation is important in developing treatment strategies due to the complexity of the vascular architecture, such as the feeding vessels, shunt points, and draining veins. In the present study, we report a case of hemorrhagic perimedullary CCJ-AVF with multiple feeding vessels in which the common single draining vein was dissected by craniotomy and completely treated.</p></div><div><h3>Case presentation</h3><p>A 71-year-old woman presented with subarachnoid hemorrhage (Hunt &amp; Kosnik, grade II). Cerebrovascular CTA showed no intracranial cerebral aneurysm and findings suggestive of shunt disease at the CCJ. Based on cerebral angiography, the patient was diagnosed with perimedullary CCJ AVF, with the right radicular and the left anterior spinal arteries as feeders which drain into a common dilated coronary vein through a shunt located on the ventral side of the spinal cord and then drain into the ascending and descending anterior spinal veins. Ventricular drainage was performed for acute hydrocephalus, and arteriovenous fistula was dissected electively by craniotomy on day 17 after onset. A clip was applied to the single draining vein, which had been evaluated using preoperative imaging diagnosis. Intraoperative digital subtraction angiography (DSA) confirmed the disappearance of shunt blood flow, and the surgery was completed. The follow-up DSA did not show shunt blood flow, and the patient was transferred to a rehabilitation hospital with a modified Rankin scale score of 2.</p></div><div><h3>Conclusion</h3><p>CCJ-AVF cases often have a complex vascular architecture, and it is important to use various modalities to understand the vascular anatomy in detail and develop an appropriate treatment strategy.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 3","pages":"Pages 132-135"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49746189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms 新冠肺炎的神经并发症和影响:症状和可能的机制
Q4 CLINICAL NEUROLOGY Pub Date : 2023-09-01 DOI: 10.1016/j.hest.2023.02.001
Elif Sarıoğlu, Sezen Yılmaz Sarıaltın, Tülay Çoban

A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. The new coronavirus disease (COVID-19) was declared a global pandemic by the World Health Organization (WHO) in March 2020. SARS-CoV-2 can invade the nervous system aside from infecting the respiratory system as its primary target. The most common nervous system symptoms of COVID-19 are stated as headache, myalgia, fatigue, nausea, vomiting, sudden and unexplained anosmia, and ageusia. More severe conditions such as encephalomyelitis, acute myelitis, thromboembolic events, ischemic stroke, intracerebral hemorrhage, Guillain-Barré-syndrome, Bell's palsy, rhabdomyolysis, and even coma have also been reported. Cohort studies revealed that neurological findings are associated with higher morbidity and mortality. The neurological symptoms and manifestations caused by SARS-CoV-2 and COVID-19 are examined and summarized in this article.

2019年12月,在中国武汉首次发现了一种新型冠状病毒,即严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。2020年3月,世界卫生组织(世界卫生组织)宣布新型冠状病毒疾病(新冠肺炎)为全球大流行。严重急性呼吸系统综合征冠状病毒2型除了作为主要目标感染呼吸系统外,还可以入侵神经系统。新冠肺炎最常见的神经系统症状是头痛、肌痛、疲劳、恶心、呕吐、突然和不明原因的嗅觉缺失和老年痴呆。更严重的情况,如脑脊髓炎、急性脊髓炎、血栓栓塞事件、缺血性中风、脑出血、格林-巴利综合征、贝尔麻痹、横纹肌溶解症,甚至昏迷也有报道。队列研究显示,神经系统的发现与更高的发病率和死亡率有关。本文综述了严重急性呼吸系统综合征冠状病毒2型和新冠肺炎引起的神经系统症状和表现。
{"title":"Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms","authors":"Elif Sarıoğlu,&nbsp;Sezen Yılmaz Sarıaltın,&nbsp;Tülay Çoban","doi":"10.1016/j.hest.2023.02.001","DOIUrl":"https://doi.org/10.1016/j.hest.2023.02.001","url":null,"abstract":"<div><p>A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. The new coronavirus disease (COVID-19) was declared a global pandemic by the World Health Organization (WHO) in March 2020. SARS-CoV-2 can invade the nervous system aside from infecting the respiratory system as its primary target. The most common nervous system symptoms of COVID-19 are stated as headache, myalgia, fatigue, nausea, vomiting, sudden and unexplained anosmia, and ageusia. More severe conditions such as encephalomyelitis, acute myelitis, thromboembolic events, ischemic stroke, intracerebral hemorrhage, Guillain-Barré-syndrome, Bell's palsy, rhabdomyolysis, and even coma have also been reported. Cohort studies revealed that neurological findings are associated with higher morbidity and mortality. The neurological symptoms and manifestations caused by SARS-CoV-2 and COVID-19 are examined and summarized in this article.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 3","pages":"Pages 154-173"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49747061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brain Hemorrhages
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1